Soligenix, Inc. - Common Stock (NQ:SNGX)

0.3654 +0.0016 (+0.44%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soligenix, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 27, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 27, 2022

Via Benzinga

Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket ↗

December 27, 2022

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-market trading on heavy volume.

Via Benzinga

Soligenix Delivers Two Pivotal Milestones

December 20, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Recap: Soligenix Q2 Earnings ↗

August 12, 2022

Soligenix (NASDAQ:SNGX) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Soligenix Shares Gain On HyBrytes Data From Blood Cancer Study ↗

July 20, 2022

Via Benzinga

7 Stocks to Add to Your 10x Watchlist ↗

December 16, 2022

It’s always a good time to look for stocks with exceptional growth potential. Here are seven 10x stocks for your watchlist.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 15, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 15, 2022

Via Benzinga

Soligenix Positioned for Growth: Late-stage Pipeline and Key Q4 Milestones

December 06, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

UPDATE: Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat with PCG Advisory

November 16, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat With PCG Advisory

November 16, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 14, 2022

Gainers Imara (NASDAQ:IMRA) stock moved upwards by 37.2% to $3.54 during Friday's pre-market session. The market value of their outstanding shares is at $93.0 million.

Via Benzinga

Soligenix Enters Q4 With Multiple Catalysts in Play

October 13, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

11 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 23, 2022

Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.

Via Benzinga

FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's HyBryte for CTCL

September 12, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Soligenix Earnings Perspective: Return On Capital Employed ↗

September 09, 2022

According to Benzinga Pro data, during Q2, Soligenix (NASDAQ:SNGX) posted sales of $400 thousand. Earnings were up 45.12%, but Soligenix still reported an overall loss of $2.39 million.

Via Benzinga

Could This Company's HyBryte™ Provide A Safer, More Convenient Alternative To Cutaneous T-Cell Lymphoma Treatment? ↗

August 17, 2022

Patients always have hope if their cancers are detected early. Thanks to advanced research and therapies, the earlier the cancer is diagnosed and treated, the better the chance of it being cured.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 28, 2022

Gainers

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Soligenix's HyBryte Treatment Now Within Reach for Rare Cancer Patients

July 26, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact ↗

July 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Soligenix Partners With SERB Pharmaceuticals To Supply Ricin Antigen For Ricin Toxin Poisoning Treatment ↗

July 25, 2022

Via Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 20, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 07, 2022

Gainers

Via Benzinga

Soligenix Gets FDA Nod For Mid-Stage Psoriasis Study ↗

June 28, 2022

The U.S. Food and Drug Administration (FDA) has cleared Soligenix’s (NASDAQ: SNGX) Investigational New Drug (IND) application for Phase 2a clinical trial Evaluating SGX302 in the treatment of patients...

Via Benzinga

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives ↗

June 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 28, 2022

Via Benzinga

Soligenix Moves Forward with Treatments for Cutaneous T-Cell Lymphoma and Psoriasis

June 07, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.